tiprankstipranks
Trending News
More News >
Hepion Pharmaceuticals (HEPA)
OTHER OTC:HEPA
US Market

Hepion Pharmaceuticals (HEPA) Income Statement

Compare
780 Followers

Hepion Pharmaceuticals Income Statement

Last quarter (Q4 2024), Hepion Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Hepion Pharmaceuticals's net income was $-1.55M. See Hepion Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -67.13K$ -77.46K$ -86.07K$ -34.52K
Operating Expenses
$ 19.35M$ 48.45M$ 43.62M$ 30.40M$ 20.15M
Depreciation and Amortization
$ -1.94M$ 67.13K$ 77.46K$ 86.07K$ 34.52K
EBITDA
$ -19.35M$ -49.26M$ -43.54M$ -30.32M$ -20.11M
Operating Income
$ -19.35M$ -48.45M$ -45.49M$ -30.40M$ -20.15M
Other Income/Expenses
$ 3.18M$ -887.11K$ 404.83K$ -2.32M$ -177.28K
Pretax Income
$ -16.16M$ -49.34M$ -45.08M$ -32.72M$ -20.32M
Net Income
$ -13.19M$ -48.93M$ -42.20M$ -32.72M$ -20.35M
Per Share Metrics
Basic EPS
$ -107.35$ -12.32$ -11.07$ -9.31$ -42.06
Diluted EPS
$ -107.35$ -12.32$ -11.07$ -9.31$ -42.06
Weighted Average Shares Outstanding
122.89K 3.97M 3.81M 3.51M 483.89K
Weighted Average Shares Outstanding (Diluted)
122.89K 3.97M 3.81M 3.51M 483.89K
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis